Glimmers in illuminating the druggable genome

Glimmers in illuminating the druggable genome, Published online: 19 January 2018; doi:10.1038/nrd.2017.252

Much biomedical research continues to focus on a small proportion of the human genome that has already been studied intensively. The Illuminating the Druggable Genome programme, initiated as a pilot project by the US National Institutes of Health Common Fund in 2014, is now being implemented to accelerate the investigation of subsets of understudied proteins that have potential therapeutic relevance.

中文翻译：

---

照亮可药用基因组的一瞥

照亮可药用基因组的一瞥

阐明可药用基因组的瞥见者，在线发布：2018年1月19日; doi：10.1038 / nrd.2017.252

许多生物医学研究继续集中在已经进行了深入研究的一小部分人类基因组上。由美国国立卫生研究院共同基金于2014年发起的试点项目“发光药物基因组计划”目前正在实施中，以加速对具有潜在治疗意义的未充分研究的蛋白质子集的研究。